| Transaction Date | Recipient | Shares | Type | Price | Value |
|---|---|---|---|---|---|
| 22nd September 2020 | Advisors Llc Perceptive | 1,644,785 | Conversion of derivative | $0.00 | |
| 22nd September 2020 | Advisors Llc Perceptive | 1,058,824 | Open or private purchase | $17.00 | $18,000,008.00 |
| 15th September 2020 | Advisors Llc Perceptive | 2,911,764 | Open or private purchase | $4.25 | $12,374,997.00 |
| 14th September 2020 | Advisors Llc Perceptive | 400,000 | Open or private purchase | $40.00 | $16,000,000.00 |
| 14th September 2020 | Advisors Llc Perceptive | 1,800,000 | Open or private purchase | $11.00 | $19,800,000.00 |
| 10th September 2020 | Advisors Llc Perceptive | 200,000 | Open or private purchase | $11.24 | $2,248,000.00 |
| 17th August 2020 | Joel S Marcus | 4,000 | Open or private sale | $171.52 | $686,080.00 |
| 17th August 2020 | Joel S Marcus | 3,500 | Open or private sale | $173.51 | $607,285.00 |
| 12th August 2020 | Joel S Marcus | 7,959 | Open or private sale | $14.15 | $112,619.85 |
| 11th August 2020 | Joel S Marcus | 7,500 | Open or private sale | $13.86 | $103,950.00 |
Meira G Tx Holdings Plc
MeiraGTx Holdings Plc is a clinical-stage biotech company. It engages in the development of novel gene therapy treatments. The company was founded on March 20, 2015 and is headquartered in New York, NY.
Ticker: MGTX
Sector: Health Technology
Industry: Biotechnology
SEC Central Index Key (CIK): 1735438
Employees: 157
Exchange: NASDAQ
Auditor Opinion:
You must Login to see Language Changes
Disclosure Language changes
You must Login to see analysis
Red Flags
There were no Red Flags found
Fundamentals
Cash at Carrying Value: $195 M (-14%)
Other Assets, Current: $2 M (-5%)
Assets, Current: $235 M (-12%)
Property, Plant and Equipment, Net: $28 M (16%)
Other Assets, Noncurrent: $194 Th (0%)
Assets: $291 M (-10%)
Accounts Payable, Current: $3 M (-17%)
Accrued Liabilities, Current: $18 M (0%)
Liabilities, Current: $47 M (-5%)
Liabilities: $118 M (-11%)
Common Stock, Value, Issued: $1 Th (1%)
Common Stock, Shares, Issued: $37 M (1%)
Retained Earnings (Accumulated Deficit): $244 M (0%)
Accumulated Other Comprehensive Income (Loss), Net of Tax: $3 M (48%)
Stockholders' Equity (Parent): $173 M (0%)
Liabilities and Equity: $291 M (-10%)
Revenue: $2 M (-62%)
Research and Development: $16 M (-33%)
General and Administrative Expenses: $11 M (-50%)
Operating Income/Loss: $25 M (-38%)
Provision for income taxes: $91 Th (0%)
News
Travel Insurance Facilities Plc apology
15th September 2020
Juvenescence Announces Licensing Agreement with Evgen Pharma plc
15th September 2020
Top 5 Vendors in the Calcium Carbonate Market- COVID Impact | Technavio
15th September 2020
